1. Assessment of contour variability in target volumes and organs at risk in lung cancer radiotherapy. (June 2019) Authors: Tsang, Yatman; Hoskin, Peter; Spezi, Emiliano; Landau, David; Lester, Jason; Miles, Elizabeth; Conibear, John Journal: Technical innovations & patient support in radiation oncology Issue: Volume 10(2019) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 33 Development of an intervention to support lung cancer patients and their clinicians when considering systematic anti-cancer therapy: the pact study, a prospective multi-centre multi-methods five-stage qualitative study. Issue 3 (1st September 2018) Authors: Nelson, Annmarie; Byrne, Anthony; Sivell, Stephanie; Longo, Mirella; Noble, Simon; Lester, Jason; Anagnostou, Despina; Sampson, Catherine Journal: BMJ supportive & palliative care Issue: Volume 8:Issue 3(2018) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Six versus three-weekly pembrolizumab: as well-tolerated?. (June 2021) Authors: Williams, Fiona; John, Rebecca; Davies, Rhian; Brewster, Alison; Edwards, Bleddyn; Davies, Mari; Lester, Jason Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Running on faith : the principles, passion, and pursuit of a winning life /: the principles, passion, and pursuit of a winning life. (©2010) Other Names: Lester, Jason; Vandehey, Tim Record Type: Book Extent: 1 online resource (xiv, 206 pages, [8] pages of plates), color illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. (June 2022) Authors: Fennell, Dean A.; Porter, Catharine; Lester, Jason; Danson, Sarah; Taylor, Paul; Sheaff, Michael; Rudd, Robin M; Gaba, Aarti; Busacca, Sara; Nixon, Lisette; Gardner, Georgina; Darlison, Liz; Poile, Charlotte; Richards, Cathy; Jordan, Peter-Wells; Griffiths, Gareth; Casbard, Angela Journal: EClinicalMedicine Issue: Volume 48(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin. (19th May 2020) Authors: Jones, Robert; Crabb, Simon; Chester, John; Elliott, Tony; Huddart, Robert; Birtle, Alison; Evans, Linda; Lester, Jason; Jagdev, Satinder; Casbard, Angela; Huang, Chao; Madden, Tracie‐Ann; Griffiths, Gareth Journal: BJU international Issue: Volume 126:Number 2(2020) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial. (October 2022) Authors: Fennell, Dean A.; Porter, Catharine; Lester, Jason; Danson, Sarah; Blackhall, Fiona; Nicolson, Marianne; Nixon, Lisette; Gardner, Georgina; White, Ann; Griffiths, Gareth; Casbard, Angela Journal: EClinicalMedicine Issue: Volume 52(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development of an intervention to support patients and clinicians with advanced lung cancer when considering systemic anticancer therapy: protocol for the PACT study. Issue 7 (12th July 2017) Authors: Anagnostou, Despina; Sivell, Stephanie; Noble, Simon; Lester, Jason; Byrne, Anthony; Sampson, Catherine; Longo, Mirella; Nelson, Annmarie Journal: BMJ open Issue: Volume 7:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Issue 10260 (31st October 2020) Authors: Parker, Christopher C; Clarke, Noel W; Cook, Adrian D; Kynaston, Howard G; Petersen, Peter Meidahl; Catton, Charles; Cross, William; Logue, John; Parulekar, Wendy; Payne, Heather; Persad, Rajendra; Pickering, Holly; Saad, Fred; Anderson, Juliette; Bahl, Amit; Bottomley, David; Brasso, Klaus; Chah... Journal: Lancet Issue: Volume 396:Issue 10260(2020) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023) Authors: Brown, Janet E; Royle, Kara-Louise; Gregory, Walter; Ralph, Christy; Maraveyas, Anthony; Din, Omar; Eisen, Timothy; Nathan, Paul; Powles, Tom; Griffiths, Richard; Jones, Robert; Vasudev, Naveen; Wheater, Matthew; Hamid, Abdel; Waddell, Tom; McMenemin, Rhona; Patel, Poulam; Larkin, James; Faust, G... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗